Volume 16, Number 11—November 2010
Dispatch
Multidrug-Resistant Salmonella enterica Serovar Infantis, Israel
Ohad Gal-Mor
, Lea Valinsky, Miriam Weinberger, Sara Guy, Joseph Jaffe, Yosef Ilan Schorr, Abraham Raisfeld, Vered Agmon, and Israel Nissan
, Lea Valinsky, Miriam Weinberger, Sara Guy, Joseph Jaffe, Yosef Ilan Schorr, Abraham Raisfeld, Vered Agmon, and Israel Nissan
Table
Antimicrobial drug resistance patterns of Salmonella enterica serovar Infantis isolates, sorted by isolation year, Israel*
| Antimicrobial drug resistance profile | PFGE pattern |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1970–2005 |
2007 |
2008 |
2009 |
Total |
|||||||||
| I1 | D | I1 | D | I1 | D | I1 | D | ||||||
| Ampicillin, cefuroxime, ceftriaxone, cephalothin, nitrofurantoin, trimethoprim/sulfamethoxazole | 1 | 1 | |||||||||||
| Ampicillin, cefepime, ceftriaxone, cephalothin, cefuroxime, tobramycin | 1 | 1 | |||||||||||
| Nitrofurantoin | 5 | 5 | |||||||||||
| Nitrofurantoin, tetracycline | 1 | 1 | |||||||||||
| Levofloxacin, nalidixic acid | 1 | 1 | |||||||||||
| Nalidixic acid, nitrofurantoin, tetracycline | 1 | 1 | 37 | 3 | 8 | 3 | 53 | ||||||
| Nalidixic acid, nitrofurantoin, tetracycline, cephalothin | 1 | 1 | |||||||||||
| Nalidixic acid, nitrofurantoin, tetracycline, trimethoprim/sulfamethoxazole | 2 | 1 | 1 | 10 | 1 | 15 | |||||||
| Nalidixic acid, tetracycline, trimethoprim/sulfamethoxazole | 1 | 1 | |||||||||||
| Nalidixic acid, tetracycline | 1 | 1 | |||||||||||
| Nalidixic acid, trimethoprim/sulfamethoxazole |
1 |
1 |
|||||||||||
| Sensitive to all tested antimicrobial drugs |
6 |
6 |
|||||||||||
| Total | 16 | 2 | 3 | 47 | 7 | 9 | 3 | 87 | |||||
*PFGE, pulsed-field gel electrophoresis; I1, emerging PFGE pattern; D, different from the emerging pattern.
Page created: March 03, 2011
Page updated: March 03, 2011
Page reviewed: March 03, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.